Early use of non invasive ventilation in patients with amyotrophic lateral sclerosis: What benefits?

European Review for Medical and Pharmacological Sciences

Volumn 19, Issue 22, 2015, Pages 4304-4313

  Terzano, C ^a   Romani, S ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Amyotrophic lateral sclerosis; Forced expiratory volume in one second; Hypercapnia; Maximal inspiratory pressures; Non invasive mechanical ventilation; Vital capacity

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BLOOD GAS ANALYSIS; BREATHING MUSCLE; CLINICAL ARTICLE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; LUNG INSUFFICIENCY; LUNG PRESSURE; MALE; MAXIMAL INSPIRATORY PRESSURE; MUSCLE STRENGTH; NONINVASIVE VENTILATION; PATIENT COMPLIANCE; RISK BENEFIT ANALYSIS; SPIROMETER; TOTAL LUNG CAPACITY; VITAL CAPACITY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RISK ASSESSMENT; TIME FACTOR; UTILIZATION;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; BLOOD GAS ANALYSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; MUSCLE STRENGTH; NONINVASIVE VENTILATION; RESPIRATORY FUNCTION TESTS; RESPIRATORY MUSCLES; RISK ASSESSMENT; TIME FACTORS; VITAL CAPACITY;

EID: 84958093325     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. ORRELL RW. Understanding the causes of amyotrophic lateral sclerosis. N Engl J Med 2007; 357: 822-823.
2. HIRTZ D, THURMAN DJ, GWINN-HARDY K, MOHAMED M, CHAUDHURI AR, ZALUTSKY R. How common are the common neurological disorders? Neurology 2007; 68: 326-337.
3. PREUX PM, COURATIER P, BOUTROS-TONI F, SALLE JY, TABARAUD F, BERNET-BERNADY P, VALLAT JM, DUMAS M. Survival prediction in amyotrophic lateral sclerosis. Neuroepidemiology 1996; 15: 153-160.
4. HOWARD RS, ORRELL RW. Management of motor neurone disease. Postgrad Med J 2002; 78: 736-741.
5. ANDERSEN PM, BORASIO GD, DENGLER R, HARDIMAN O, KOLLEWE K, LEIGH PN, PRADAT PF, SILANI V, TOMIK B. EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. Eur J Neurol 2005; 12: 921-938.
6. MILLER RG, JACKSON CE, KASARSKIS EJ, ENGLAND JD, FORSHEW D, JOHNSTON W, KALRA S, KATZ JS, MITSUMOTO H, ROSENFELD J, SHOESMITH C, STRONG MJ, WOOLLEY SC. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies C. Terzano, S. Romani (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009; 73: 1218-1226.
7. PEREZ T. Neuromuscular disorders: assessment of the respiratory muscles. Rev Neurol 2006;4:437-444
8. FARRERO E, ANTÓN A, EGEA CJ, ALMARAZ MJ, MASA JF, UTRABO I, CALLE M, VEREA H, SERVERA E, JARA L, BARROT E, CASOLIVÉ V. Guidelines for the management of respiratory complications in patients with neuromuscular disease. Arch Bronconeumol 2013; 49: 306-313.
9. MILLER RG, ROSENBERG JA, GELINAS DF, MITSUMOTO H, NEWMAN D, SUFIT R, BORASIO GD, BRADLEY WG, BROMBERG MB, BROOKS BR, KASARSKIS EJ, MUNSAT TL, OPPENHEIMER EA. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology 1999; 52: 1311-1323.
10. RADUNOVIC A, ANNANE D, RAFIQ MK, MUSTFA N. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev 2013; 3: CD004427.
11. WORLD FEDERATION OF NEUROLOGY RESEARCH GROUP ON NEUROMUSCULAR DISEASES. Subcommittee on motor neuron diseases. El Escorial World Federation of Neurology Criteria for the diagnosis of Amyotrophic Lateral Sclerosis. J Neurol Sci 1994; 124: 96-107.
12. MILLER MR, HANKINSON J, BRUSASCO V, BURGOS F, CASABURI R, COATES A, CRAPO R, ENRIGHT P, VAN DER GRINTEN CP, GUSTAFSSON P, JENSEN R, JOHNSON DC, MACINTYRE N, MCKAY R, NAVAJAS D, PEDERSEN OF, PELLEGRINO R, VIEGI G, WANGER J; ATS/ERS TASK FORCE. Standardisation of spirometry. Eur Respir 2005; 26: 319-338.
13. SCHIFFMAN PL, BELSH JM. Pulmonary function at diagnosis of amyotrophic lateral sclerosis. Rate of deterioration. Chest 1993; 103: 508-513.
14. TSARA V, SERASLI E, STEIROPOULOS P, TSOROVA A, ANTONIADOU M, ZISI P. Respiratory function in amyotrophic lateral sclerosis patients. The role of sleep studies. Hippokratia 2010; 14: 33-36.
15. SIMILOWSKI T, ATTALI V, BENSIMON G, SALACHAS F, MEHIRI S, ARNULF I, LACOMBLEZ L, ZELTER M, MEININGER V, DERENNE JP. Diaphragmatic dysfunction and dyspnoea in amyotrophic lateral sclerosis. Eur Respir J 2000; 15: 332-337.
16. TRAYNOR BJ1, ZHANG H, SHEFNER JM, SCHOENFELD D, CUDKOWICZ ME; NEALS CONSORTIUM. Functional outcome measures as clinical trial endpoints in ALS. Neurology 2000; 63: 1933-1935.
17. STAMBLER N, CHARATAN M, CEDARBAUM JM. Prognostic indicators of survival in ALS. Neurology 1998; 50: 66-72.
18. MILLER RG, MITCHELL JD, LYON M, MOORE DH. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Amyotroph Lateral Scler Other Motor Neuron Disord 2003; 4: 191-206.
19. CZAPLINSKI A, YEN AA, APPEL SH. Amyotrophic lateral sclerosis: early predictors of prolonged survival. J Neurol 2006; 253: 1428-1436.
20. LEONARDIS L, DOLENC GROŠELJ L, VIDMAR G. Factors related to respiration influencing survival and respiratory function in patients with amyotrophic lateral sclerosis: a retrospective study. Eur J Neurol 2012; 19: 1518-1524.
21. LEIGH PN, ABRAHAMS S, AL-CHALABI A, AMPONG MA, GOLDSTEIN LH, JOHNSON J, LYALL R, MOXHAM J, MUSTFA N, RIO A, SHAW C, WILLEY E. The management of motor neurone disease. J Neurol Neurosurg Psychiatry 2003; 74: iv32-iv47.
22. AMERICAN THORACIC SOCIETY. Dyspnea. Mechanisms, assessment, and management: a consensus statement. Am J Respir Crit Care Med 1999; 159: 321-340.
23. POLKEY MI, LYALL RA, GREEN M, NIGEL LEIGH P, MOXHAM J. Expiratory muscle function in amyotrophic lateral sclerosis. Am J Respir Crit Care Med 1998; 158: 734-741.
24. FARRERO E, PRATS E, POVEDANO M, MARTINEZ-MATOS JA, MANRESA F, ESCARRABILL J. Survival in amyotrophic lateral sclerosis with home mechanical ventilation: the impact of systematic respiratory assessment and bulbar involvement. Chest 2005; 127: 2132-2138.
25. ALMEIDA S, SILVA LB, GUERREIRO CA, NUCCI A. Amyotrophic lateral sclerosis Prospective study on respiratory parameters. Arq Neuropsiquiatr 2010; 68: 258-262.
26. TERZANO C, DI STEFANO F, CONTI V, DI NICOLA M, PAONE G, PETROIANNI A, RICCI A. Mixed acid-base disorders, hydroelectrolyte imbalance and lactate production in hypercapnic respiratory failure: the role of noninvasive ventilation. PLoS One 2012; 7: e35245.
27. QUANJER PH, LEBOWITZ MD, GREGG I, MILLER MR, PEDERSEN OF. Peak expiratory flow: conclusions and recommendations of a Working Party of the European Respiratory Society. Eur Respir J 1997; 10: 2s-8s.
28. BRACH B. Expiratory flow patterns in amyotrophic lateral sclerosis. Chest 1979; 75: 648-649.
29. SATHYAPRABHA TN, PRADHAN C, NALINI A, THENNARASU K, RAJU TR. Pulmonary function tests and diaphragmatic compound muscle action potential in patients with sporadic amyotrophic lateral sclerosis. Acta Neurol Scand 2010; 121: 400-405.
30. VITACCA M, CLINI E, FACCHETTI D, PAGANI M, POLONI M, PORTA R, AMBROSINO N. Breathing pattern and respiratory mechanics in patients with amyotrophic lateral sclerosis. Eur Respir J 1997; 10: 1614-1621.
31. FREGONEZI G, ARAÚJO PR, MACÊDO TL, DOURADO JUNIOR ME, RESQUETI VR, ANDRADE ADE F. Monitoring respiratory muscle strength assists in early diagnosis of respiratory dysfunction as opposed to the isolated use of pulmonary function evaluation in amyotrophic lateral sclerosis. Arq Neuropsiquiatr 2013; 71: 146-152.